Literature DB >> 9074431

Activated protein C resistance in homozygous sickle cell disease.

J G Wright1, P Cooper, R G Malia, A E Kulozik, B Vetter, P Thomas, F E Preston, G R Serjeant.   

Abstract

The activated protein C resistance (APC-R) ratios in 50 patients with steady state homozygous sickle cell (SS) disease and 59 healthy AA controls was measured. There was a significant reduction in median APC-R ratio in sickle cell disease compared to controls. This reduction in APC-R ratio was not explained by (1) the presence of the factor V Leiden, found in only one of 165 patients with SS disease including those tested for APC-R, or (2) the presence of lupus anticoagulants. However, the raised levels of factor VIIIC in SS patients in this study may be contributing to increased resistance to APC, which in turn may contribute to the vaso-occlusive complications of SS disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9074431     DOI: 10.1046/j.1365-2141.1997.d01-2084.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

Review 1.  Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics.

Authors:  Zahra Pakbaz; Ted Wun
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

2.  Sickle cell disease and venous thromboembolism.

Authors:  Zohreh Rahimi; Abbas Parsian
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-05-24       Impact factor: 2.576

3.  A 19-year-old man with sickle cell disease presenting with spinal infarction: a case report.

Authors:  April Edwards; E Leila Jerome Clay; Valerie Jewells; Stacie Adams; Regina D Crawford; Rupa Redding-Lallinger
Journal:  J Med Case Rep       Date:  2013-08-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.